SCHEMBL8353030

SCHEMBL8353030

Cc1ccc(C2(CNC3CCC3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.49
SLC6A3 Q01959 6/20 0.49
SLC6A2 P23975 3/20 0.49
KDM4E B2RXH2 1/20 0.42
HPGD P15428 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
F10 P00742 1/20 0.36
ACHE P22303 1/20 0.35
BACE1 P56817 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8353275 0.97 SLC6A4 (0.49) SLC6A4SLC6A3SLC6A2KDM4EHPGD
SCHEMBL8354044 0.95 SLC6A4 (0.51) SLC6A4SLC6A3SLC6A2KDM4EHPGD
SCHEMBL8353273 0.93 SLC6A4 (0.51) SLC6A4SLC6A3SLC6A2KDM4EHPGD
SCHEMBL8353668 0.92 SLC6A4 (0.51) SLC6A4SLC6A3SLC6A2KDM4EHPGD
SCHEMBL8350796 0.90 SLC6A4 (0.60) SLC6A4SLC6A3SLC6A2KDM4ESMN1; SMN2
SCHEMBL8353178 0.77 KDM4E (0.42) SLC6A4SLC6A3SLC6A2KDM4ESMN1; SMN2
SCHEMBL8353023 0.74 SLC6A4 (0.58) SLC6A4SLC6A3SLC6A2
SCHEMBL8353652 0.74 KDM4E (0.43) SLC6A4SLC6A3SLC6A2KDM4EHPGD
SCHEMBL14347879 0.74 SLC6A4 (0.43) SLC6A4SLC6A3SLC6A2KDM4ESMN1; SMN2
SCHEMBL10840847 0.73 LMNA (0.63) SLC6A4SLC6A3SLC6A2KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed